Litigation Details for AstraZeneca LP v. InvaGen Pharmaceuticals Inc. (D. Del. 2017)
✉ Email this page to a colleague
AstraZeneca LP v. InvaGen Pharmaceuticals Inc. (D. Del. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-08-02 |
Court | District Court, D. Delaware | Date Terminated | 2018-03-08 |
Cause | 35:0145 | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Parties | ASTRAZENECA UK LIMITED | ||
Patents | 7,250,419; 7,265,124; RE46,276 | ||
Attorneys | Michael P. Kelly | ||
Firms | Kratz & Barry LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in AstraZeneca LP v. InvaGen Pharmaceuticals Inc.
Details for AstraZeneca LP v. InvaGen Pharmaceuticals Inc. (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2018-03-15 | 13 | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE 46,276; 7,250,419; 7,265,124. (…2017 9 March 2018 1:17-cv-01073 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
2017-08-02 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE46,276; 7,250,419; 7,265,124…2017 9 March 2018 1:17-cv-01073 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |